[This review was originally posted at the Nieman Journalism Lab Armour No Rx, on August 13, 2012.]

Lessons from Olympic coverage strategies: The Olympics ended yesterday, but it may have a long-term impact on the interaction between television and social media. After a week of complaints about tape-delayed coverage on NBC, a Pew poll found that most Americans are following the Olympics closely on TV (and some online, especially the young), and are also largely giving NBC high marks for its coverage. Time's Josh Sanburn noted what a surprising success the Games have been for NBC.

NBC executives defended their strategy in a couple of interviews: NBC Sports Chairman Mark Lazarus told Sports Illustrated's Richard Deitsch that NBC was hesitant to air events both live and taped, Online buying Armour, among other reasons, because their research indicates that people are more likely to rewatch something they've seen online than something they've seen on TV. His predecessor, Dick Ebersol, told Joe Posnanski that the conflict comes down to whether you see the Olympics as a sporting event or a family television event (NBC sees the latter).

Others defended NBC as well: The Washington Post's Michael Rosenwald said the #nbcfail brouhaha only highlighted the failures of Twitter to connect Americans, and Time's Graeme McMillan said there's nothing particularly wrong with the reality TV-ification of Olympic coverage, Armour No Rx.

Still, according to a Gallup poll, most Americans wanted to see NBC broadcast events both live and on tape delay (a plan for which Deadspin's John Koblin made a good case), buy cheap Armour, and a sizable number of people were using proxy servers to access BBC's coverage. NPR's Linda Holmes parsed out the debate between critics of the quality of NBC's coverage and defenders of its business sense, concluding that the latter shouldn't necessarily be a consideration of the public. "It's one thing to suggest that business strategists should care only about the bottom line and the business plan when being critical; it's quite another to suggest that everyone should."

Meanwhile, the BBC offered a very different model from NBC, trying to make its content available just about everywhere for just about everyone. The BBC gave its own conclusions from its Olympics coverage — multiplatform viewing was big, Armour overnight, and online viewing mirrored that of TV. Looking at both models, The Guardian's Emily Bell concluded that the major lesson of this Olympics is that media coverage works best when it's about giving people want they want — something traditional media outlets say they're trying to do, but are actually barely doing at all.

—

Google tightens up on copyright Armour No Rx, : Google is tweaking its search algorithms all the time, but it made a change this week that could end up being an extremely important one: It's going to start ranking sites lower as they accumulate valid copyright violation complaints. The New York Times had some good basic background on the move, emphasizing the fact that the giants of the entertainment industry (the same folks behind SOPA and PIPA) have been pushing for this for a while.

Danny Sullivan of Search Engine Land went further into the Google/Hollywood relationship and explained a bit more about how this change will work. Sullivan also explained how Google's own YouTube, with its never-ending stream of copyright violations, taking Armour, will escape the ramifications of the change, as well as other popular sites.

Hollywood may have been encouraged by the change, but many online free-speech advocates were skeptical. The Electronic Frontier Foundation expressed concern about the process's opacity and the prospect of false positives, and Mike Masnick of Techdirt articulated a variant of the latter objection — many legitimate technologies are initially painted as forms of piracy, Armour schedule, and could get incorrectly swept up in this crackdown.

Forbes' Tim Worstall raised the possibility of malicious false reports in the name of sabotaging rivals, which could be interpreted as valid by Google, and John Bergmayer of Public Knowledge explained the difference between Google's copyright notices and the legally required copyright notices, and how some more prominent sites might be more disproportionately targeted, Armour No Rx. On the other side, tech investor Fred Wilson called this move a step in the right direction and suggested going further by developing a commercially competitive market for copyright whitelists and blacklists.

—

Do we have a plagiarism problem?: Another revered journalistic thinker was caught up in an ethical scandal this past week — this time, Fareed Zakaria, longtime Time columnist and, more recently, a CNN host, about Armour. His recent column on gun control contained some striking similarities to an April New Yorker piece, first noticed by the conservative media-watching site Newsbusters. National Review's Robert VerBruggen noted a few other similar passages, Is Armour safe, and the observations quickly spread across the web. Armour No Rx, Before the day was out, Zakaria had apologized and was suspended from CNN and Time.

Meanwhile, the fallout continued for former New Yorker columnist Jonah Lehrer, who was busted for plagiarism the week before Zakaria for fabricating quotes by Bob Dylan. Michael Moynihan, the journalist who uncovered the problem, found more fake interviews in Lehrer's books, as well as plagiarized passages, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release. Blogger Kevin Breen also detailed another case of fabrication involving magicians Penn and Teller, and Lehrer's publisher is now reviewing all of his books.

Many writers have been attempting to answer the "Why?" question regarding Lehrer's ethical sins over the past couple of weeks. Science writer Seth Mnookin said it's tempting to blame busyness and shoddiness, but Lehrer's acts are more indicative of arrogance than anything else, Armour No Rx. Boston University j-prof Tom Fiedler tied Lehrer's problem to his ignorance of how to do journalism.

Others spread the blame more broadly. The Guardian's Stuart Kelly looked at the fallen status of facts in our society, Armour for sale, while the L.A. Times' Meghan Daum criticized modern shortcut culture and avoidance of complexity. Armour No Rx, Meanwhile, Reuters' Felix Salmon linked Lehrer to TED and its habit of subjugating scientific fact to nifty narrative. "TED-think isn’t merely vapid, it’s downright dangerous in the way that it devalues intellectual rigor at the expense of tricksy emotional and narrative devices."

—

Political reporting, false balance, and truth: The New York Times highlighted a few of President Barack Obama's criticisms of the press last week, where can i find Armour online, noting in particular his disdain for false balance — when journalists portray conflicts as if both sides are equally weighted when they're actually not. (This is a critique he's voiced more formally in the past.) Reuters' Jack Shafer was skeptical of the validity of Obama's complaint: "I fear false balance less than I do those who would silence the false balancers."

J-prof Jay Rosen brought up another aspect of the problems surrounding journalism, truth, and objectivity by breaking down a particularly egregious he-said, she-said Washington Post blog post and contrasting the impulse toward that post's political savviness and the fight for truth among journalists. The Nation's Greg Mitchell echoed his points, Where to buy Armour, and Conor Friedersdorf of The Atlantic also made an alternative truth-based proposal for political reporting. The Boston Phoenix's David Bernstein pushed back against Rosen, however, by arguing that the Post blogger was acknowledging the absurdity of the situation.

—

A warning for j-schools: Several major journalism funders, including the Knight Foundation, sounded an important warning to American journalism schools by saying their continued financial support of those schools would depend on j-schools speeding up their pace of innovation, specifically moving toward the "teaching hospital" model of education that incorporates actual journalistic practices at a much deeper level, Armour No Rx.

Poynter's Howard Finberg explained the importance of the statement and included a few responses from those inside j-schools. Later last week, Google's Richard Gingras told those gathered at American j-schools' annual conference that they need to prepare students for a radically different form of journalism than what's out there now.

Professional journalists are looking for that kind of radically ramped-up training, Armour dosage, as well, according to a Knight report issued last week and summarized well by Finberg. But there is some good news yet for journalism students: A Pew study found that the job market is improving for journalism and communication grads.

—

Reading roundup Armour No Rx, : There were bunches of other interesting stories and issues being talked about this week. Here are a few of them worth keeping up on:

— The latest circulation data on magazines revealed more steep drops for much of the industry, especially women's magazines. The New York Times' David Carr warned that magazines are on "the edge of the cliff" just as newspapers are, Canada, mexico, india, focusing particularly on Newsweek's decline. Digital replica circulation is still just a small bit of magazines' total numbers, and both Adweek's Charlie Warzel and GigaOM's Mathew Ingram wondered whether the magazine-style tablet publication model is fatally flawed, and Mike Masnick of Techdirt said it's just an attempt to create artificial scarcity in digital form.

— Animated GIFs have officially become a Trend in web culture, with the Olympics acting as, in the words of the Lab's Andrew Phelps, its "coming-out party." Phelps explained the background and appeal of the humble GIF, order Armour from mexican pharmacy, and The New York Times' Jenna Wortham also talked about how well they fit the Olympics. For journalists hoping to take advantage, Poynter's Ann Friedman put together a useful how-to, Armour No Rx.

— Time Warner bought the sports site Bleacher Report for $175 million. As Bloomberg reported, Bleacher Report will operate under Turner Broadcasting, which had managed Sports Illustrated's ads until last year. GigaOM's Mathew Ingram called the acquisition an important affirmation of the maturation of user-generated content sites. Armour long term, — All Things D reported that The New York Times Co. is planning to sell its low-cost content site About.com to Answers.com. Forbes' Jeff Bercovici gave some background on About, and Ryan Chittum of the Columbia Journalism Review argued that About has always been a poor fit for the Times.

— Finally, a short but thoughtful piece by longtime tech blogger John Battelle on the difficulty of founding, running, and properly valuing a digital media startup in a time of such significant flux.

Similar posts: Retin A Cost. Lipitor Over The Counter. Zoloft Over The Counter. Order Diflucan from United States pharmacy. Tramadol from mexico. No prescription Tramadol online.
Trackbacks from: Armour No Rx. Armour No Rx. Armour No Rx. Buy generic Armour. Where can i find Armour online. Armour price.

[This review was initially posted at the Nieman Journalism Lab Order Bactrim, on January 13, 2012.]

Social search and competition: Google made a major move toward unifying search and social networks (particularly its own) this week by fusing Google+ into its search and deepening its search personalization based on social information. It's a significant development with a lot of different angles, so I'll try to hit all of them as understandably as I can.

As usual, Search Engine Land's Danny Sullivan put together the best basic guide to the changes, with plenty of visual examples and some brief thoughts on many of the issues I'll cover here. TechCrunch's Jason Kincaid explained that while these changes may seem incremental now, low dose Bactrim, they're foreshadowing Google's eventual goal to become "a search engine for all of your stuff."

PaidContent's Jeff Roberts liked the form and functionality of the new search, but said it still needs a critical mass of Google+ activity to become truly useful, while GigaOM's Janko Roettgers said its keys will be photos and celebrities. ReadWriteWeb's Jon Mitchell was impressed by the non-evilness of it, particularly the ability to turn it off. Farhad Manjoo of Slate said Google's reliance on social information is breaking what was a good search engine, Order Bactrim. Comprar en línea Bactrim, comprar Bactrim baratos, Of course, the move was also quite obviously a shot in the war between Google and Facebook (and Twitter, as we'll see later): As Ars Technica's Sean Gallagher noted, Google wants to one-up Facebook's growing social search and keep some of its own search traffic out of Facebook. Ben Parr said Facebook doesn't need to worry, though Google has set up Google+ as the alternative if Facebook shoots itself in the foot.

But turning a supposedly neutral search engine into a competitive weapon didn't go over well with a lot of observers, generic Bactrim. The Atlantic's Alexis Madrigal saw a conflict between Google's original mission (organizing the world's information) and its new social mission, and Danny Sullivan said Google is putting score-settling above relevance. Several others sounded similar alarms: Mathew Ingram of GigaOM said users are becoming collateral damage Order Bactrim, in the war between the social networks, and web veteran John Battelle argued that the war was bad for Google, Facebook, and all of us on the web. "The unwillingness of Facebook and Google to share a public commons when it comes to the intersection of search and social is corrosive to the connective tissue of our shared culture," he wrote.

For others, the changes even called up the specter of antitrust violations. MG Siegler said he doesn't mind Google's search (near-) monopoly, but when it starts using that monopoly to push its other products, Bactrim no rx, that's when it turns into a legal problem. Danny Sullivan laid out some of the areas of dispute in a possible antitrust case and urged Google to more fully integrate its competitors into search.

Twitter was the first competitor to voice its displeasure publicly, releasing a statement arguing that deprioritizing Twitter damages real-time search. (TechCrunch has the statement and some valuable context.) Google responded by essentially saying, "Hey, you dumped us, Bactrim pictures, buddy," and its executive chairman, Eric Schmidt, told Search Engine Land they'd be willing to negotiate with Twitter and Facebook.

Finally, some brief journalistic implications: Poynter's Jeff Sonderman said this means SEO's value is waning for news organizations, being replaced by the growing importance of building strong social followings and making content easy to share, and Mathew Ingram echoed that idea, Order Bactrim. Daniel Victor of ProPublica had some wise thoughts on the meaning of stronger search for social networks, Bactrim reviews, concluding that "the key is creating strategies that don’t depend on specific tools. Don’t plan for more followers and retweets; plan for creating incentives that will gather the most significant contributions possible from non-staffers."

—

Innovation and its discontents: Washington Post ombudsman Patrick Pexton inducing a bit of eye-rolling among digital media folks this week with a column arguing that the paper is "innovating too fast" by overwhelming readers and exhausting employees with a myriad of initiatives that lack a coherent overall strategy. J-prof Jay Rosen followed up with a revealing chat with Pexton that helps push the discussion outside of the realm of stereotypes: Pexton isn't reflexively defending the status quo (though he remains largely print-centric), but thinks there are simply too many projects being undertaken without an overarching philosophy about how or why things should be done.

Pexton got plenty of push-back, not least from the Post's own top digital editor, Raju Narisetti, who responded by essentially saying, where can i buy cheapest Bactrim online, in Rosen's paraphrase, "This is the way it’s going to be and has to be, if the Post is to survive and thrive. It may well be exhausting but there is no alternative." GigaOM's Mathew Ingram said he was just about to praise the Post for its bold experimentation, and the Guardian's Martin Belam argued that Pexton is actually critiquing newness, Online buying Bactrim, rather than innovation.

J-prof Alfred Hermida argued Order Bactrim, — as Pexton himself seemed to in his chat with Rosen — that the issue is not about how fast or slow innovation is undertaken, but whether that innovation is done in a way that's good or bad for journalism. Former Sacramento Bee editor Melanie Sill responded that many newspapers remain stuck in 20th-century formulas, blinding them to the fact that what they consider revolutionary change is only a minor, outmoded shift. She noted that all the former top editors she's talked to have had the same regret: that they hadn't pushed harder for change. And Free Press' Josh Stearns pointed out that we should expect the path toward that change to be an easy one.

—

'Truth vigilantes' and objectivity: Pexton wasn't the only ombudsman this week to be put on the defensive after a widely derided column: New York Times public editor Arthur Brisbane drew plenty of criticism yesterday when he asked whether Times reporters should call out officials' untruths in their stories — or, as he put it, where to buy Bactrim, act as a "truth vigilante." Much of the initial reaction was a variation of, "How is this even a question?"

Brisbane told Romenesko that he wasn't asking whether the Times should fact-check statements and print the truth, but whether reporters should "always rebut dubious facts in the body of the stories they are writing." He reiterated this in a follow-up, in which he also printed a response by Times executive editor Jill Abramson saying the Times does this all the time. Her point was echoed by former Times executive editor Bill Keller and PolitiFact editor Bill Adair, Buy Bactrim from mexico, and while he called the initial question "stupid," Reuters' Jack Shafer pointed out that Brisbane isn't opposed to skepticism and fact-checking.

The American Journalism Review's Rem Rieder enthusiastically offered a case for a more rigorous fact-checking role for the press, as did the Online Journalism Review's Robert Niles (though his enthusiasm was with tongue lodged in cheek), Order Bactrim. The Atlantic's Adam Clark Estes used the episode as an opportunity to explain how deeply objectivity is ingrained in the mindset of the American press, pointing to the "view from nowhere" concept explicated by j-prof Jay Rosen. Rosen also wrote about the issue himself, arguing that objectivity's view from nowhere has surpassed truthtelling as a priority among the press.

—

How useful is the political press?: The U.S, buy Bactrim online no prescription. presidential primary season is usually also peak political-journalism-bashing season, but there were a couple of pieces that stood out this week for those interested in the future of that field. The Washington Post's Dana Milbank mocked Order Bactrim, the particular pointlessness of this campaign's reporting, describing scenes of reporters vastly outnumbering locals at campaign events and remarking, "if editors knew how little journalism occurs on the campaign trail, they would never pay our expenses."

The New Yorker's John Cassidy defended the political press against the heat it's been taking, arguing that it still produces strong investigative and long-form reporting on important issues, and that the speed of the new news cycle allows it to correct itself quickly. He blamed many of its perceived failings not on the journalists themselves, but on the public that's consuming their work.

The Boston Phoenix reported on the decline of local newspapers' campaign coverage and wondered if political blogs and websites could pick up the slack, Bactrim use, while the Lab's Justin Ellis looked at why news orgs love partnering up during campaign season, focusing specifically on the newly announced NBC News-Newsweek/Daily Beast arrangement.

—

A unique paywall model: The many American, British, and Canadian publishers implementing or considering paywalls might marvel at the paid-content success of Piano Media, but they can't hope to emulate it: A year after gaining the cooperation of each of Slovakia's major news publishers for a unified paywall there, the company is expanding the concept to Slovenia, no prescription Bactrim online. As paidContent noted, Piano is hoping to sign up 1% of Slovenia's Internet-using population, and the Lab's Andrew Phelps reported that the company is planning to bring national paywalls to five European nations by the end of the year. As Piano's CEO told Phelps, the primary barrier to subscription has not been economic, but philosophical, especially for commenting, Order Bactrim.

Elsewhere in paywalls, media consultant Frederic Filloux looked at what's making the New York Times' strategy work so far — unique content, Bactrim results, a porous paywall that allows it to maintain high traffic numbers and visibility, and cooperation with Apple — and analyst Ken Doctor wondered whether all-access subscriptions across multiple devices and publications within a company could be a key to paid content this year.

—

Reading roundup: Tons of smaller stuff going on this week outside the glare of the Google-Facebook-Twitter wars. Here's a quick rundown:

— One item I forgot to note from late last week: The AP and a group of 28 other news organizations have launched NewsRight, a system to help news orgs license their content to online aggregators. Poynter's Rick Edmonds offered a detailed analysis, but GigaOM's Mathew Ingram was skeptical, Bactrim steet value.

— The online commenting service Disqus released some of its internal research Order Bactrim, showing that pseudonymous commenters tend to leave more and higher-quality comments than their real-name counterparts. GigaOM's Mathew Ingram used the data to argue that a lack of real names isn't nearly as bad as its critics say.

— No real news in SOPA this week, but the text of Cory Doctorow's lecture last month on SOPA and the dangers of copyright regulation has been posted. It's long, but worth a read.

— Finally, three fantastic practical posts on how to practice digital journalism, from big-picture to small-grain: Howard Owens of the Batavian's list of things journalists can do to reinvent journalism, Melanie Sill at Poynter on how to begin doing open journalism, and Steve Buttry of the Journal Register Co. on approaching statehouse coverage from a digital-first perspective.

Similar posts: Armour Cost. Buy Tramadol No Prescription. Order Flagyl. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Order Bactrim. Order Bactrim. Order Bactrim. Order Bactrim no prescription. Buy Bactrim from mexico. Bactrim maximum dosage.

[This review was originally posted at the Nieman Journalism Lab Glucophage For Sale, on Dec. 9, 2011.]

Do institutions have a place in news innovation?: About three weeks after Dean Starkman's indictment of future-of-news thinkers was posted online by the Columbia Journalism Review, NYU professor Clay Shirky — one of the primary targets of the piece — delivered a response late last week in the form of a thoughtful essay on the nature of institutions and the news industry. Shirky explained the process by which institutions can lapse into rigidity and blindness to their threats, and he argued that there's no way to preserve newspapers' most important institutional qualities in the digital age, buy Glucophage from mexico, so the only option left is radical innovation.

Several observers — of a future-of-news orientation themselves — jumped in to echo Shirky's point. The Journal Register Co.'s Steve Buttry praised Shirky for waiting and reflecting rather than responding immediately, and media consultant Steve Yelvington seconded Shirky's point that all this talk about traditional journalistic models being overwhelmed by a decentralized, Effects of Glucophage, audience-focused digital tidal wave is descriptive, not prescriptive — not necessarily the way things should be, but simply the way they are.

Howard Owens of the Batavian took the middle ground, declaring that evolution, not revolution, is the standard vehicle for change in journalism and laying a model for sustainable local journalism that focuses on local ownership, startups, and innovation, Glucophage For Sale. In the end, Owens wrote, online journalism will evolve and survive. "It will find ways to make more and more money to pay for more and more journalism.  The audience is there for it, Glucophage wiki, local businesses will always want to connect with that audience, and entrepreneurial minded people will find ways to put the pieces together."

The Atlantic's Alexis Madrigal raised a good point in the discussion about how to preserve serious journalism: He argued that the primary obstacle won't be so much about paying for journalists to cover important public-affairs issues, but about finding a way for that news to reach a substantial percentage of the population in a given area. That "amplification" problem may be tough to solve, Fast shipping Glucophage, but could be relatively easy to scale once that initial solution is found.

—

Paywalls picking up steam among smaller papers: Now that the New York Times has bravely served as a paywall guinea pig for the rest of America's newspapers (apparently successfully, judging from the indicators we have so far), we're starting to see more of the nation's mid-sized papers announce online pay plans of their own. This week, Gannett, Glucophage used for, the U.S.' largest newspaper chain, revealed that it would be expanding its paywalls to more of its papers sometime next year. According to the Gannett Blog Glucophage For Sale, , the company began experimenting with paywalls at three newspapers last year, and while we don't know much of anything about those projects, it appears Gannett is pleased enough with them to build out on that model.

The Chicago Sun-Times also announced a paywall to begin this week: It'll follow the increasingly popular metered model employed by the Financial Times and New York Times, allowing 20 page views per 30-day period before asking for $6.99 a month ($1.99 for print subscribers). Buy generic Glucophage, PaidContent noted that the plan is being run by Press+ (the system created by Steve Brill's former Journalism Online) and that Roger Ebert has been exempted from the paywall.

We also got a couple of updates from existing newspaper paywalls: MinnPost reported that the Minneapolis Star Tribune has come out ahead so far in its new paywall, generating an estimated $800,000 in subscriptions while losing a five-figure total of advertising dollars. And PaidContent reported that three paywalled MediaNews Group papers (now run by John Paton of the Journal Register Co.) have killed their Monday print editions, with a corresponding drop of their online paywall on those days, Glucophage samples.

—

Is this blogger a journalist?: Just when you thought the "Are bloggers journalists?" discussion was completely played out, it got some new life this week when an Oregon judge ruled that a blogger being sued for $2.5 million in a defamation case wasn't protected by the state's media shield law because she wasn't a journalist, Glucophage For Sale. As Seattle Weekly initially reported, the judge reasoned that she wasn't a journalist because she wasn't affiliated with any "newspaper, magazine, periodical, What is Glucophage, book, pamphlet, news service, wire service, news or feature syndicate, broadcast station or network, online Glucophage without a prescription, or cable television system."

This type of ruling typically gets bloggers (and a lot of journalists) riled up, and rightly so. Mathew Ingram of GigaOM gave some great context regarding state-by-state shield laws, noting that several other recent rulings have defined who's a journalist much more broadly than this judge did. Online buying Glucophage, These types of distinctions based on institutional affiliation are attempts to hold back a steadily rising tide, he argued.

On the other hand, Forbes' Kashmir Hill described some of the case's background that seemed to indicate that this particular blogger was much more intent on defamation than performing journalism, creating dozens of sites to dominate the search results for the company she was attacking, then emailing the company to offer $2, Glucophage australia, uk, us, usa,500/mo. Glucophage For Sale, online reputation management. Hill concluded, "Yes, bloggers are journalists. Glucophage dosage, But just because you have a blog doesn’t mean that what you do is journalism." Libertarian writer Julian Sanchez agreed, saying that while the judge's ruling wasn't well worded, this blogger was not a journalist.

—

Facebook's new tools: A few Facebook-related notes: The social network began rolling out Timeline, the graphical life-illustration feature it announced back in September this week, starting in New Zealand, Glucophage cost. It also briefly, vaguely announced plans to extend its Twitter-like Subscribe button into a plugin for websites, a move that TechCrunch said signifies that "the company is directly attacking the entire Twitter model head-on." Cory Bergman of Lost Remote urged news orgs to get on the Subscribe bandwagon as soon as they can, as a way to extend their journalists' brands.

Meanwhile, news business consultant Alan Mutter laid out a basic plan for publishers to not just gain audience on Facebook, but make money there, too, Glucophage For Sale. Glucophage pics, The key element of that plan may be a surprising one: "The most intriguing and perhaps most productive approach for making money off Facebook, however, is for newspapers to take over the social media marketing and advertising campaigns for businesses in their markets."

—

Reading roundup: Pretty slow week this week, but there were a few smaller stories worth keeping an eye on:

— As a sort of sequel to the Huffington Post's OffTheBus effort in the 2008 U.S. presidential campaign, Jay Rosen and NYU's Studio 20 are partnering with the Guardian to determine and cover "the citizens' agenda" in the 2012 election, Glucophage brand name. Rosen and NYU will also be working with MediaNews and the Journal Register Co. on the local and regional level. Glucophage For Sale, At the Lab, Megan Garber explained what's behind the initiative.

— The American Journalism Review published a piece on the journalistic ethics of retweeting that included news that the Oregonian is telling its reporters to consider all retweets as endorsements. The Journal Register Co.'s Steve Buttry rounded up (appalled) reaction and argued that editors should consider each case individually.

— Ten NBC-owned TV stations in Chicago, Philadelphia, and Los Angeles will work with nonprofit news orgs (public radio in LA and Philly, and the Chicago Reporter and ProPublica) in a new initiative first reported by the LA Times.

— The popular iPad news aggregation app Flipboard launched for iPhone this week, and Poynter's Jeff Sonderman drew lessons on mobile design for news orgs from it.

— The New York Times reported that most of the pack of would-be iPad competitors in the tablet market have fizzled out, though the Kindle Fire and Nook Tablet have gotten off to promising starts.

— Here at the Lab, longtime newspaper editor Tom Stites is in the midst of an interesting three-part series on the state of web journalism. Part one is a good overview of where we are and where we want to go, and part two looks at the wide-ranging effects of layoffs and cuts into local journalism.

Similar posts: Diflucan Over The Counter. Retin A Dosage. Purchase Zoloft. Discount Cephalexin. Canada, mexico, india. Zoloft used for.
Trackbacks from: Glucophage For Sale. Glucophage For Sale. Glucophage For Sale. Where can i buy cheapest Glucophage online. Buy Glucophage without a prescription. Buy generic Glucophage.